UB Paderborn / Katalog / Suche / in CDI

1 – 18 von 18

Sortiert nach

Fracture rates and economic outcomes in patients with osteoporosis prescribed risedronate gastro-resistant versus other oral bisphosphonates: a claims data analysis

Osteoporosis international, 2022-01, Vol.33 (1), p.217-228

2022

Link zum Volltext

Verfügbarkeit prüfen

A review of the pharmacology, clinical outcomes, and real-world effectiveness, safety, and non-contraceptive effects of NOMAC/E2

European journal of obstetrics & gynecology and reproductive biology: X, 2024-03, Vol.21, p.100283-100283, Article 100283

2024

Link zum Volltext

Verfügbarkeit prüfen

Cost-effectiveness of weekly gastro-resistant risedronate 35 mg, compared with weekly alendronate 70 mg tablets, in the treatment of postmenopausal osteoporosis in Spain

Journal of comparative effectiveness research, 2023-11, Vol.12 (11), p.e230115-e230115

2023

Link zum Volltext

Verfügbarkeit prüfen

Treatment compliance and venous thromboembolism risk in women receiving estradiol/micronised progesterone vs conjugated estrogens/medroxyprogesterone

Maturitas, 2023-07, Vol.173, p.71-72

2023

Link zum Volltext

Verfügbarkeit prüfen

Is the multinational, surveillance PRO-E2 study informative for all countries? The Italian data on VTE and contraceptive effectiveness

The European journal of contraception & reproductive health care, 2024-02, Vol.29 (1), p.1-7

2024

Link zum Volltext

Verfügbarkeit prüfen

The women’s menopause tool: content validity of a novel assessment for menopause treatment decision making

Maturitas, 2023-07, Vol.173, p.73

2023

Link zum Volltext

Verfügbarkeit prüfen

Modeling and simulation of sexual activity daily diary data of patients with female sexual arousal disorder treated with sildenafil citrate (Viagra®)

Pharmaceutical research, 2006-08, Vol.23 (8), p.1756-1764

2006

Link zum Volltext

Verfügbarkeit prüfen

Fracture risk in women with osteoporosis initiated on gastro-resistant risedronate versus immediate release risedronate or alendronate: a claims data analysis in the USA

Osteoporosis international, 2023-05, Vol.34 (5), p.977-991

2023

Link zum Volltext

Verfügbarkeit prüfen

Amenorrhea rates in women treated with novel oral, continuous hormonal therapy of body identical 17β-estradiol and micronized progesterone

Maturitas, 2021-10, Vol.152, p.85-86

2021

Link zum Volltext

Verfügbarkeit prüfen

Novel oral combined 17β-estradiol (E2) and micronized progesterone (P4) therapy improves vasomotor symptoms (VMS) and sleep in postmenopausal women (PW)

Maturitas, 2021-10, Vol.152, p.85-85

2021

Link zum Volltext

Verfügbarkeit prüfen

Linzagolix therapy versus a placebo in patients with endometriosis-associated pain: a prospective, randomized, double-blind, Phase 3 study (EDELWEISS 3)

Human reproduction (Oxford), 2024-06, Vol.39 (6), p.1208-1221

2024

Link zum Volltext

Verfügbarkeit prüfen

Oral estradiol/micronized progesterone may be associated with lower risk of venous thromboembolism compared with conjugated equine estrogens/medroxyprogesterone acetate in real-world practice

Maturitas, 2023-06, Vol.172, p.23-31

2023

Link zum Volltext

Verfügbarkeit prüfen

Development of a Questionnaire on Sexual Quality of Life in Women

Journal of sex & marital therapy, 2005-10, Vol.31 (5), p.385-397

2005

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of Sildenafil Citrate (Viagra) in Men with Premature Ejaculation

Journal of sexual medicine, 2005-05, Vol.2 (3), p.368-375

2005

Link zum Volltext

Verfügbarkeit prüfen

Growth hormone excess and galactorrhoea without acromegalic features. Case reports

BJOG : an international journal of obstetrics and gynaecology, 1991-01, Vol.98 (1), p.92-97

1991

Link zum Volltext

Verfügbarkeit prüfen

A pilot study of the effect of viagra® on vaginal blood flow (VBF) in female subjects

International journal of gynecology and obstetrics, 2000, Vol.70 (S4), p.D65-D65

2000

Link zum Volltext

Verfügbarkeit prüfen

Development of a sexual function questionnaire for clinical trials of female sexual dysfunction

Journal of women's health & gender-based medicine, 2002-04, Vol.11 (3), p.277-289

2002

Link zum Volltext

Verfügbarkeit prüfen

Restenosis after percutaneous transluminal angioplasty

The American journal of surgery, 1998-08, Vol.176 (2), p.102-108

1998

Link zum Volltext

Verfügbarkeit prüfen

1 – 18 von 18

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(17)
Mit Volltextzugriff
(17)

Publikationsform

Artikel
(18)

Sprache

Englisch
(18)
Japanisch
(1)

Erscheinungsjahr

n.n

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Fracture rates and economic outcomes in patients with osteoporosis prescribed risedronate gastro-resistant versus other oral bisphosphonates: a claims data analysis

A review of the pharmacology, clinical outcomes, and real-world effectiveness, safety, and non-contraceptive effects of NOMAC/E2

Cost-effectiveness of weekly gastro-resistant risedronate 35 mg, compared with weekly alendronate 70 mg tablets, in the treatment of postmenopausal osteoporosis in Spain

Treatment compliance and venous thromboembolism risk in women receiving estradiol/micronised progesterone vs conjugated estrogens/medroxyprogesterone

Is the multinational, surveillance PRO-E2 study informative for all countries? The Italian data on VTE and contraceptive effectiveness

The women’s menopause tool: content validity of a novel assessment for menopause treatment decision making

Modeling and simulation of sexual activity daily diary data of patients with female sexual arousal disorder treated with sildenafil citrate (Viagra®)

Fracture risk in women with osteoporosis initiated on gastro-resistant risedronate versus immediate release risedronate or alendronate: a claims data analysis in the USA

Amenorrhea rates in women treated with novel oral, continuous hormonal therapy of body identical 17β-estradiol and micronized progesterone

Novel oral combined 17β-estradiol (E2) and micronized progesterone (P4) therapy improves vasomotor symptoms (VMS) and sleep in postmenopausal women (PW)

Linzagolix therapy versus a placebo in patients with endometriosis-associated pain: a prospective, randomized, double-blind, Phase 3 study (EDELWEISS 3)

Oral estradiol/micronized progesterone may be associated with lower risk of venous thromboembolism compared with conjugated equine estrogens/medroxyprogesterone acetate in real-world practice

Development of a Questionnaire on Sexual Quality of Life in Women

Efficacy of Sildenafil Citrate (Viagra) in Men with Premature Ejaculation

Growth hormone excess and galactorrhoea without acromegalic features. Case reports

A pilot study of the effect of viagra® on vaginal blood flow (VBF) in female subjects

Development of a sexual function questionnaire for clinical trials of female sexual dysfunction

Restenosis after percutaneous transluminal angioplasty

Suchergebnisse filtern